Bacteriophage-based microbial source-tracking studies are an economical and simple way of identifying fecal sources in polluted water systems. Recently isolated Bacteroides spp. strains ARABA 84, and GB-124 have been shown to detect bacteriophages exclusively in aquatic systems impacted by human fecal material. To date, limited examination of the occurrence or concentration of phages capable of infecting Bacteroides fragilis strain GB-124 or B. thetaiotaomicron strain ARABA 84 in human and animal feces has been carried out. This study reports the prevalence rates and concentrations of phages infecting ARABA 84 and GB-124 host strains in human and a range of animal feces. Discrete human fecal samples (n ¼ 55) and pooled animal samples (n ¼ 46, representing the feces of over 230 animals) were examined for phages infecting the host strains ARABA 84, GB-124, and E. coli strain WG5. Both human Bacteroides host strains were highly specific (95% and 100% for ARABA 84 and GB-124, respectively), challenging results from previous studies.
INTRODUCTION
Microbial source tracking is an emerging field in Switzerland, and its use is limited. It is therefore of importance to demonstrate the usability of both the proposed Swiss strain (ARABA 84), and also one of the most promising strains (GB-124) so MST in Switzerland can be developed. At present, little is known regarding the sensitivity or specificity of phages infecting B. fragilis strain GB-124 or B. thetaiotaomicron strain ARABA 84 in fecal samples from a range of hosts in Switzerland. By undertaking an assessment of host specificity and sensitivity of both host strains, we aimed to both further validate the use of phages infecting ARABA 84, while assessing the geographical applicability of phages infecting UK Bacteroides strain GB-124 in Switzerland as indicators of aquatic human fecal material. This objective will be achieved by carrying out an investigation into the prevalence rates and levels of these phages in fecal samples of human and animal origin.
Only after demonstrating high specificity can both Bacteroides indicators be employed with confidence in Swiss waterbodies for MST purposes. Furthermore, B. fragilis strain GB-124 is emerging as one of the most promising host strains for the detection of human fecal material globally. By undertaking a regional assessment of specificity/ sensitivity, information will be provided regarding the geographical stability of these MST markers.
MATERIALS AND METHODS
Two types of sample were used in the study: (1) discrete human fecal samples and (2) pooled animal fecal samples; the details of these samples are given in full below.
Fecal sample collection and processing
Animal fecal samples (typically up to 50 g) were collected in sterile sampling pots (Sarstedt, Germany) from different farms in three Swiss Cantons (Bern, Solothurn, and Luzern), and transported to the laboratory on the same, or the next day; samples were chilled in either an insulated cool box or a refrigerator during transportation and storage, respectively. Samples were a composite of the feces of between two and seven animals (with the majority of samples being composed of the feces of five or more animals), either freshly voided or removed during rectal examination. All animal fecal samples were diluted 10-fold using peptone saline solution (pH 7.2), and mixed by magnetic stirring for 1 h. Large particles were then sedimented by low-speed centrifugation (2,000-4,000 × g) for 10 min at 4 W C, and the supernatant filtered using 0.22 μm hydrophilic polyethersulfone membranes (MillexGP, Millipore, USA).
To the filtrate, glycerol was then added to a final concentration of 10% (vol/vol); samples were divided into three separate 15 ml polypropylene tubes (Sarstedt, Germany) and stored at À70 W C until analysis. Logarithmic dilutions of each fecal suspension were assayed in duplicate. For animal samples, 10 À1 to 10 À5 dilutions of original fecal material were assayed for somatic coliphages, and a 10 À1 dilution of original fecal material assayed for phages infecting Bacteroides spp., strains GB-124 and ARABA 84.
Discrete human fecal samples were sourced from healthy male and female subjects as part of a company's employment induction scheme. Owing to the low volume of human fecal material in some samples (33 out of 55 samples), to obtain sufficient test solution for assays it was necessary to create 100fold dilutions; the remaining 22 human samples were processed using a 1:10 dilution of original fecal material.
Human samples were then processed and stored as detailed above for the animal samples. A 10 À1 dilution was assayed for 22 samples, and a 10 À2 dilution was assayed for the remaining 33 samples for three phage groups (GB-1244, ARABA 84, and somatic coliphages). Where positive plates were above 200 PFU/ml in the greatest dilution, samples were repeated using new aliquots from frozen, and assayed at greater dilution factors.
Phage assays
Both human and animal fecal samples were assayed for When both were present, levels of phages infecting ARABA 84 were lower than somatic coliphages, and overall median values were 6.7 × 10 3 PFU/g and 2.0 × 10 3 PFU/g, respectively (SD ¼ 1.6 × 10 7 and 9.2 × 10 3 ), though as ARABA 84 phages were only recorded in two samples, further statistical analyses could not be carried out.
Host strain sensitivity and specificity 100
a total of approximately 230 discrete fecal samples), and therefore the specificity may be higher if discrete samples were to be assayed.
In agreement with results published by Ebdon et al. ). As environmental fecal pollution will be derived from a group, rather than individual subjects, the low prevalence rates for GB-124 and ARABA 84 are unlikely to limit the use of either host strain in MST studies. Within raw fecal material it is therefore more important for a method to demonstrate high specificity than high sensitivity.
The NPVs of phages infecting ARABA 84 and GB-124 are also low (48% and 46%, respectively), but are compar- The data presented here, 73%, are in accordance with the prevalence rates given above, albeit at the higher end, and as reported extensively in the literature, confirms the usefulness of somatic coliphages as a general fecal indicator.
The prevalence rate of all three phage types in human feces may have been influenced by the limits of detection used in this study (10 PFU/g for 22 samples, 100 PFU/g for the remaining 33 samples). Gantzer et al. () reported that 93% of positive human fecal samples (total number of positive samples ¼ 21) recorded in a French study contained phages able to infect HSP-40 at levels between 1 and 10 PFU/g. It is possible that phages infecting all three studied host strains have higher prevalence rates in human feces than
were measurable in the current study. It is suggested that an enrichment step, followed by qualitative spot-tests, would be useful in future studies to give exact prevalence rates.
When compared with those given for other Bacteroides It is therefore recommended that both host strains be used in combination to detect fecal pollution of human origin in Swiss waterbodies.
CONCLUSIONS
The results given in this study show that phages infecting 
